Clinical trial

PP13 and Doppler Study to Predict Preeclampsia

NCT00928213

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2009-08-01

PhasePHASE2 / PHASE3

Study timeline

Study start (unknown)2009-08-01Date precision: month

Registry last updated2009-06-25

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Preeclampsiaverified · MONDO: preeclampsia

Interventions

ProgesteroneDRUG · verified · RxNorm: progesterone

Low molecular weight HeparinDRUG

Sponsors & collaborators

Ben-Gurion University of the Negevlead sponsor

Diagnostic Technologies Ltd.collaborator

Perkin Elmer Inc.collaborator

Medical University of Grazcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00928213 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.